In summary, PTEN suppresses AKT activation, thereby inhibiting NR2F1 expression and subsequently decreasing cilia-related gene expression, leading to inhibition of bronchial epithelial hyperplasia in EGFRL858R-induced lung cancer. Here, AKT1 is linked to lung cancer.